Biotech · Private company · San Diego, CA, US
Modulo Bio, Inc.
Track this companyFree. Adds Modulo Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- The Therapeutic Development of a Clinical NR1H3 Antisense Oligonucleotide to Reprogram Microglia into a Neuroprotective State in ALS and FTDFiscal year 2026 · $847.7KNIH RePORTER 1R44NS143633-01A1 · fetched Nov 12, 2026
- Developing an AI-Guided Triculture Platform to Model NeuroHIV specific Microglial States Under ART Suppression with CellPaint/Morphological and Transcriptomic ReadoutsFiscal year 2026 · $1.5MNIH RePORTER 1R61MH143793-01 · fetched Nov 12, 2026
- Implementing a coupled system of integrative ML modeling and data validation for elucidating microglial therapeutic targets in neurodegenerative diseaseFiscal year 2024 · $1.4MNIH RePORTER 5R44MH135465-02 · fetched Nov 12, 2026